Literature DB >> 28236368

Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.

Justin C Sowder1, Richard B Cannon1, Luke O Buchmann1,2,3, Jason P Hunt1,2, Ying Hitchcock2, Shane Lloyd2, Kenneth F Grossmann2, Marcus M Monroe1,2,3.   

Abstract

BACKGROUND: National guidelines support both surgical and radiotherapy (RT) as initial treatment options for early-stage oral cavity squamous cell carcinoma (SCC). There remains limited data evaluating the survival outcomes of RT and the current practice patterns for these lesions.
METHODS: We conducted a retrospective review of 8274 patients in the Surveillance, Epidemiology, and End Results (SEER) database from 1988 to 2008 with T1 to T2N0M0 oral cavity SCC. Primary outcomes were 5-year overall survival (OS) and disease-specific survival (DSS).
RESULTS: Surgical therapy had significantly improved OS (140 months; p < .001) and DSS (217 months; p < .001) compared to surgery with adjuvant RT (104 and 163 months, respectively) and definitive RT (68 and 136 months, respectively). The use of radiation alone was associated with an increased T classification, hard palate, retromolar trigone primary site lesions, and advanced patient age.
CONCLUSION: Primary radiation without surgery continues to be used in a subset of early-stage oral cavity SCCs, in which it is associated with decreased OS and DSS.
© 2017 Wiley Periodicals, Inc. Head Neck 39: 876-880, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epidemiology; Surveillance; T1; T2; and End Results (SEER); cancer; early; floor of mouth; hard palate; oral cavity; prognosis; radiation; squamous cell carcinoma; surgery; survival; tongue

Mesh:

Year:  2017        PMID: 28236368     DOI: 10.1002/hed.24679

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Treatment Outcomes for Primary Retromolar Trigone Carcinoma: A Single Institution Experience.

Authors:  Uygar Levent Demir; Halide Öztürk Yanaşma
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-06-01

2.  Treatment Patterns in Veterans with Laryngeal and Oropharyngeal Cancer and Impact on Survival.

Authors:  Peter A Richardson; Sagar Kansara; George G Chen; Anita Sabichi; Andrew G Sikora; Robert B Parke; Donald T Donovan; Elizabeth Chiao; Vlad C Sandulache
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-08-09

3.  Sarcomatoid carcinoma after radiotherapy for early-stage oral squamous cell carcinoma: Case report.

Authors:  Bo Young Kim; Kyoung Rai Cho; Jung Heob Sohn; Jung Yeon Kim
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  The necessity of IIb dissection in T1-T2N0M0 oral squamous cell carcinoma: protocol for a randomized controlled trial.

Authors:  Lei Wang; Liang Wang; Xuefei Song; Chang Cui; Chunyue Ma; Bing Guo; Xingjun Qin
Journal:  Trials       Date:  2019-10-22       Impact factor: 2.279

5.  The influence of cervical lymph node number of neck dissection on the prognosis of the early oral cancer patients.

Authors:  Chieh-Yuan Cheng; Fang-Ju Sun; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2020-06-07       Impact factor: 2.080

Review 6.  Examination of care processes and treatment optimization for head and neck cancer patients in a community setting "hub and hub" model.

Authors:  Harleen K Sethi; Elijah Walker; Travis Weinsheim; Matthew J Brennan; Christopher E Fundakowski
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.